Business
ONWARD Medical Adds Entrepreneur and Neurotechnology Thought Leader Tim Denison, PhD to its Board of Directors
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Denison is Professor of Clinical Neurosciences at the University of Oxford and was previously Vice President of Research and Core Technologies at Medtronic. He is a co-founder and Chief Engineer of neurotechnology company Amber Therapeutics.ONWARD Co-Founder Professor Gregoire Courtine will continue to serve as Science Advisor. He will depart the Board of Directors
About this update from Onward Medical N.v.
[{"type":"image","alt":"ONWARD Medical NV","displaySize":"","headline":null,"caption":"ONWARD Medical NV","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":150,"url":"https://media.zenfs.com/en/globenewswire.com/ff435d5a4437f6b633ad80dab68096d0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/CPLGUw1yVOurWsVIgzW3oQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIxMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/ff435d5a4437f6b633ad80dab68096d0","width":300,"height":150}},"lazy":false},{"type":"text","content":"THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)","length":132,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Denison is Professor of Clinical Neurosciences at the University of Oxford and was previously Vice President of Research and Core Technologies at Medtronic. He is a co-founder and Chief Engineer of neurotechnology company Amber Therapeutics.","length":241,"tagName":"p"}]},{"val":[{"type":"text","content":"ONWARD Co-Founder Professor Gregoire Courtine will continue to serve as Science Advisor. He will depart the Board of Directors to address new responsibilities as Director of the Neuro-X Institute and expanded responsibilities at EPFL.","length":234,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":475,"olType":false},{"type":"text","content":"EINDHOVEN, the Netherlands, July 07, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities, today announces changes to its Board of Directors.","length":348,"tagName":"p"},{"type":"text","content":"Professor Tim Denison has been appointed to the Board of Directors and will assume the Board seat previously held by Professor Gregoire Courtine. Denison holds a Chair in Emerging Technologies by the Royal Academy of Engineering at the University of Oxford, where he is Professor of Engineering Science and Clinical Neurosciences. Denison was formerly Vice President of Research & Core Technology for the Restorative Therapies Group at Medtronic, where he helped oversee the design of next-generation neural interface and algorithm technologies for the...